Tag: Urinary Tract Infections
Cefepime-Taniborbactam Superior to Meropenem for Complicated UTI
Cefepime-taniborbactam superior for composite success, which included microbiologic and clinical success
Incidence of Pediatric UTI Decreased in Early Pandemic Period
UTI incidence decreased compared with prepandemic trends, but all measures of UTI severity decreased or remained stable
Improvement Needed in Managing UTI in Patients With Neurogenic Bladder
Providers who are not knowledgeable about neurogenic bladder or who communicate ineffectively are part of the problem
Five-Day Antibiotic Course Noninferior for Pediatric Febrile UTI
Five-day amoxicillin-clavulanate course noninferior to 10-day course for recurrence of UTI within 30 days
No Significant Increase Seen in Cystitis Diagnoses During COVID-19 Pandemic
More women diagnosed with interstitial cystitis/bladder pain syndrome, but difference was not significant
Electrofulguration Tied to Long-Term Improvement of Recurrent UTIs
Additionally, a decreased need for long-term antibiotics was seen after electrofulguration in menopausal women
Early Clean Intermittent Catheterization Recommended With Neurogenic Bladder
High-grade vesicoureteral reflux is crucial risk factor for recurrent febrile urinary tract infections in children
Urinary Biomarkers Can Differentiate IC/BPS From Other LUTDs
Urinary TNF-α and eotaxin levels can differentiate interstitial cystitis/bladder pain syndrome from other dysfunctions in men
Certain Tests for Pregnancy, Ovulation, UTIs Should Not Be Used, FDA Warns
A variety of tests for pregnancy, ovulation, urine, and breast milk should not be used because of concerns over efficacy and safety
Treatment Failure Down With Standard-Course Therapy in Pediatric UTI
Children receiving short-course therapy also had increased likelihood of asymptomatic bacteriuria or positive urine culture at follow-up
